Pathogenesis of venous thromboembolism

被引:34
作者
Becattini, C [1 ]
Agnelli, G [1 ]
机构
[1] Univ Perugia, Dipartimento Med Interna, Sez Med Interna & Cardiocasc, I-06126 Perugia, Italy
关键词
D O I
10.1097/00063198-200209000-00003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Three factors are related with the pathogenesis of venous thrombosis: (1) blood stasis, (2) hypercoagulability, and (3) vessel damage. Local and systemic factors are implicated in blood stasis. Remarkable advances have been recently achieved regarding the understanding of the concept of hypercoagulability, with special emphasis to thrombophilic molecular abnormalities. Increased thromboembolic risk has been described in patients with antithrombin III, protein C, or protein S deficiencies as well as factor V Leiden, prothrombin mutation G2021 0A, or hyperhomocystinemia. Vessel wall has a remarkable role in protecting against and in promoting thrombosis. The role of inflammation on venous thrombosis is under investigation. (C) 2002 Lippincott Williams Wilkins, Inc.
引用
收藏
页码:360 / 364
页数:5
相关论文
共 39 条
[1]
Alhenc-Gelas M, 1999, THROMB HAEMOSTASIS, V81, P506
[2]
[Anonymous], 1994, Hemostasis and thrombosis: basic principle and clinical practice
[3]
INFLUENCE OF ARTERIAL DAMAGE AND WALL SHEAR RATE ON PLATELET DEPOSITION - EXVIVO STUDY IN A SWINE MODEL [J].
BADIMON, L ;
BADIMON, JJ ;
GALVEZ, A ;
CHESEBRO, JH ;
FUSTER, V .
ARTERIOSCLEROSIS, 1986, 6 (03) :312-320
[4]
PLATELET THROMBUS FORMATION ON COLLAGEN TYPE-I - A MODEL OF DEEP VESSEL INJURY - INFLUENCE OF BLOOD RHEOLOGY, VONWILLEBRAND-FACTOR, AND BLOOD-COAGULATION [J].
BADIMON, L ;
BADIMON, JJ ;
TURITTO, VT ;
VALLABHAJOSULA, S ;
FUSTER, V .
CIRCULATION, 1988, 78 (06) :1431-1442
[5]
ENHANCEMENT BY FACTOR-V LEIDEN MUTATION OF RISK OF DEEP-VEIN THROMBOSIS ASSOCIATED WITH ORAL-CONTRACEPTIVES CONTAINING 3RD-GENERATION PROGESTAGEN [J].
BLOEMENKAMP, KWM ;
ROSENDAAL, FR ;
HELMERHORST, FM ;
BULLER, HR ;
VANDENBROUCKE, JP .
LANCET, 1995, 346 (8990) :1593-1596
[6]
BOYER C, 1986, THROMB HAEMOSTASIS, V56, P18
[7]
Broze G.J., 1994, Thrombosis and Hemorrhage, P57
[8]
Normal thrombin generation [J].
Butenas, S ;
van't Veer, C ;
Mann, KG .
BLOOD, 1999, 94 (07) :2169-2178
[9]
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia [J].
de Jonge, E ;
Dekkers, PEP ;
Creasey, AA ;
Hack, CE ;
Paulson, SK ;
Karim, A ;
Kesecioglu, J ;
Levi, M ;
van Deventer, SJH ;
van der Poll, T .
BLOOD, 2000, 95 (04) :1124-1129
[10]
Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism [J].
Ehrenforth, S ;
Prondsinski, MV ;
Aygören-Pürsün, E ;
Scharrer, I ;
Ganser, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) :276-280